Prenatal screening for trisomy 21 (Down syndrome), trisomy 18, trisomy 13, and common sex chromosome aneuploidies can be performed using the analysis of cell-free DNA (cfDNA) in the maternal circulation. Circulating cfDNA originates from both the mother and the placenta and is cleared from the maternal circulation shortly after birth.